Skip to content
Toggle Navigation
About LFSA
Our Mission
LFSA Board
Medical & Scientific Advisory Board
Genetic Counseling Advisory Group
Founders
50 Years of Progress
Impact Reports
LFSA In The News
News & Events
Upcoming Events
Recent Events
2025 LFSA Youth Workshop
2025 Climb for a Cure
7th International LFSA Symposium
LFS News
Ways to Help
Donate
Fundraise
Volunteer
Planned Giving
LFS Honor & Memorial Wall
Contact
Contact Us
Patient & Family Support
Subscribe
Toggle Navigation
About LFSA
Our Mission
LFSA Board
Medical & Scientific Advisory Board
Genetic Counseling Advisory Group
Founders
50 Years of Progress
Impact Reports
LFSA In The News
News & Events
Upcoming Events
Recent Events
2025 LFSA Youth Workshop
2025 Climb for a Cure
7th International LFSA Symposium
LFS News
Ways to Help
Donate
Fundraise
Volunteer
Planned Giving
LFS Honor & Memorial Wall
Contact
Contact Us
Patient & Family Support
Subscribe
Devoted to a world without inherited cancer
Search for:
Main Menu
What Is LFS
What Is LFS
Who Should Be Tested
Criteria for LFS
Treatment & Preventative Screening
Reproductive Concerns
LFS Glossary & FAQs
Patient & Family Resources
Family Support & Advocacy
LFSA Youth Program
Adolescent & Young Adult Health Care Transition Resources
Pediatric to Adult Healthcare Transition Tool
Webinars & Conferences
Insurance Basics
wbMRI
Reference Library
Genetic Counselor’s Library
Genetic Testing, Early Detection & Screening
Nutrition & Exercise
Lifestyles, Research & Survivors
Financial Concerns
LFS News
Family & Care Provider Toolkit
Medical & Scientific Resources
Research
Where To Get LFS Care
Treatment Facilities
Genetic Testing
Clinical Trials, Studies & Surveillance
Adolescent & Young Adult Health Care Transition Resources
Pediatric to Adult Healthcare Transition Tool
Family & Care Provider Toolkit
International Chapters
Africa
Canada
China
France
Germany
India
Italy
Japan
Latin America
Netherlands
Saudi Arabia
Singapore
Spain
Sweden
Türkiye
Donate
Pharma Test Page
Pharma Test Page
LFS Association
2026-05-08T11:28:42-04:00
wdt_ID
wdt_created_by
wdt_created_at
wdt_last_edited_by
wdt_last_edited_at
Cancer Type
Drug Brand Name
Drug Generic Name
Company
Patient Assistance Program
170
lfsweb_admin
05/08/2026 05:53 PM
lfsweb_admin
05/08/2026 05:53 PM
Melanoma
Keytruda
pembrolizumab
Merck
Visit Website
171
lfsweb_admin
05/08/2026 05:53 PM
lfsweb_admin
05/08/2026 05:53 PM
Non-Small Cell Lung
Keytruda
pembrolizumab
Merck
Visit Website
172
lfsweb_admin
05/08/2026 05:53 PM
lfsweb_admin
05/08/2026 05:53 PM
Renal Cell Carcinoma
Keytruda
pembrolizumab
Merck
Visit Website
173
lfsweb_admin
05/08/2026 05:53 PM
lfsweb_admin
05/08/2026 05:53 PM
Triple Negative Breast Cancer
Keytruda
pembrolizumab
Merck
Visit Website
174
lfsweb_admin
05/08/2026 05:53 PM
lfsweb_admin
05/08/2026 05:53 PM
Mesothelioma
Keytruda
pembrolizumab
Merck
Visit Website
175
lfsweb_admin
05/08/2026 05:53 PM
lfsweb_admin
05/08/2026 05:53 PM
Hodgkin Lymphoma
Keytruda
pembrolizumab
Merck
Visit Website
176
lfsweb_admin
05/08/2026 05:53 PM
lfsweb_admin
05/08/2026 05:53 PM
Head & Neck Cancer
Keytruda
pembrolizumab
Merck
Visit Website
177
lfsweb_admin
05/08/2026 05:53 PM
lfsweb_admin
05/08/2026 05:53 PM
Urothelial Cancer
Keytruda
pembrolizumab
Merck
Visit Website
178
lfsweb_admin
05/08/2026 05:53 PM
lfsweb_admin
05/08/2026 05:53 PM
Colorectal Cancer
Keytruda
pembrolizumab
Merck
Visit Website
179
lfsweb_admin
05/08/2026 05:53 PM
lfsweb_admin
05/08/2026 05:53 PM
Hepatocellular Cancer
Keytruda
pembrolizumab
Merck
Visit Website
180
lfsweb_admin
05/08/2026 05:53 PM
lfsweb_admin
05/08/2026 05:53 PM
Esophageal Cancer
Keytruda
pembrolizumab
Merck
Visit Website
181
lfsweb_admin
05/08/2026 05:53 PM
lfsweb_admin
05/08/2026 05:53 PM
Large B-cell Lymphoma
Keytruda
pembrolizumab
Merck
Visit Website
182
lfsweb_admin
05/08/2026 05:53 PM
lfsweb_admin
05/08/2026 05:53 PM
Gastric Cancer
Keytruda
pembrolizumab
Merck
Visit Website
183
lfsweb_admin
05/08/2026 05:53 PM
lfsweb_admin
05/08/2026 05:53 PM
Cervical Cancer
Keytruda
pembrolizumab
Merck
Visit Website
184
lfsweb_admin
05/08/2026 05:53 PM
lfsweb_admin
05/08/2026 05:53 PM
Biliary Tract Cancer
Keytruda
pembrolizumab
Merck
Visit Website
185
lfsweb_admin
05/08/2026 05:53 PM
lfsweb_admin
05/08/2026 05:53 PM
Merkel Cell Cancer
Keytruda
pembrolizumab
Merck
Visit Website
186
lfsweb_admin
05/08/2026 05:53 PM
lfsweb_admin
05/08/2026 05:53 PM
Renal Cell Carcinoma
Keytruda
pembrolizumab
Merck
Visit Website
187
lfsweb_admin
05/08/2026 05:53 PM
lfsweb_admin
05/08/2026 05:53 PM
Endometrial Cancer
Keytruda
pembrolizumab
Merck
Visit Website
188
lfsweb_admin
05/08/2026 05:53 PM
lfsweb_admin
05/08/2026 05:53 PM
Cutaneous Squamous Cell
Keytruda
pembrolizumab
Merck
Visit Website
189
lfsweb_admin
05/08/2026 05:53 PM
lfsweb_admin
05/08/2026 05:53 PM
Melanoma
Opdivo
nivolumab
Bristol Myers Squibb
Visit Website
190
lfsweb_admin
05/08/2026 05:53 PM
lfsweb_admin
05/08/2026 05:53 PM
Non-Small Cell Lung Cancer
Opdivo
nivolumab
Bristol Myers Squibb
Visit Website
191
lfsweb_admin
05/08/2026 05:53 PM
lfsweb_admin
05/08/2026 05:53 PM
Renal Cell Carcinoma
Opdivo
nivolumab
Bristol Myers Squibb
Visit Website
192
lfsweb_admin
05/08/2026 05:53 PM
lfsweb_admin
05/08/2026 05:53 PM
Gastric Cancer
Opdivo
nivolumab
Bristol Myers Squibb
Visit Website
193
lfsweb_admin
05/08/2026 05:53 PM
lfsweb_admin
05/08/2026 05:53 PM
Mesothelioma
Opdivo
nivolumab
Bristol Myers Squibb
Visit Website
194
lfsweb_admin
05/08/2026 05:53 PM
lfsweb_admin
05/08/2026 05:53 PM
Hodgkin Lymphoma
Opdivo
nivolumab
Bristol Myers Squibb
Visit Website
Cancer Type
Drug Brand Name
Drug Generic Name
Company
Patient Assistance Program
Page load link
Go to Top